Attributable length of stay, mortality risk and costs of bacterial healthcare-associated infections in Australia: a retrospective case-cohort study

  02 September 2020

Unbiased estimates of the health and economic impact of healthcare-associated infections (HAIs) are scarce and focus largely on patients with bloodstream infection (BSI). We sought to estimate the hospital length of stay (LOS), mortality and costs of HAIs and the differential effect on patients with an antimicrobial resistance (AMR) infection.

The health burden remains highest for BSIs, however the UTIs and respiratory tract infections (RTI) contributed most to the healthcare system expenditure.

Author(s): X J Lee, A J Stewardson, L J Worth, N Graves, T M Wozniak
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed